# Intestinimonas for Prevention of Type 2 Diabetes Mellitus

> **NCT04495972** · NA · COMPLETED · sponsor: **Caelus Pharmaceuticals BV** · enrollment: 26 (actual)

## Conditions studied

- PreDiabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Intestinimonas-capsules
- **DIETARY_SUPPLEMENT:** Placebo-capsules

## Key facts

- **NCT ID:** NCT04495972
- **Lead sponsor:** Caelus Pharmaceuticals BV
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-15
- **Primary completion:** 2023-09-12
- **Final completion:** 2023-11-10
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04495972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04495972, "Intestinimonas for Prevention of Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04495972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*